CRISPR to Target Leukaemia
Researchers used CRISPR gene-editing to equip certain immune cells with a homing beacon to target leukaemia.
CRISPR
2017: This Was Your Year
Now that the Festival of Genomics London is done, dusted, and in the record books, we take a look back at what you were busy reading on our website during 2017, including your answers from our survey.
CRISPR Tackles Deadly Disease That Stops The Heart From Beating
Scientists have tweaked the DNA in human heart cells to correct mutations that cause a deadly disease, which if proved safe could eventually cure children of Duchenne Muscular Dystrophy (DMD).
Stuff to Read, Week 5
This week we talk CRISPR delivery, precision medicine anno 2030, gene editing equality and three-person babies arriving in the UK.
Allele Specific Gene Editing with CRISPR
Researchers are reporting that they have performed ‘allele specific’ gene editing that could present a cure for an inherited form of blindness
The Next Gene-Editing Tool? 10 New Bacterial Immune Systems Discovered
A systematic study uncovering multiple new and unusual bacterial immune defence mechanisms could pave the way toward new biotech tools.
Festival of Genomics London 2018: What to Watch Out For
To help you plan your visit, or perhaps inspire you to sign up for your free place, we’ve put together a handy guide to this year’s theme, and some of our top picks from the agenda.
China Races Ahead in Human Gene-Editing Trials
Even though the U.S. are the closest they’ve ever been to using the gene-editing tool CRISPR in human trials, Dr. Wu and others in China are already way ahead.
FDA Approves Artificial Intelligence That Can Predict Death
The FDA has approved the very first algorithm that monitors a patient’s vitals to help predict sudden death from heart attacks or respiratory failure.
Should Self-Experimentation With Gene Editing Be Banned by the FDA?
Although very much disagreeing with biohacking practices, and strongly discouraging them, the FDA has never actually intervened themselves with individuals. Should they?
Yes, You Can Reprogram a Cell Just by Unlocking a Specific Location of the Genome
In a scientific first, researchers turned skin cells from mice into stem cells by activating a specific gene in the cells using CRISPR technology.
CRISPR Stocks Aren’t Even Close to Being Worthless
With the possibility that CRISPR-Cas9 could prove ineffective in humans, there was talk that the stocks of these biotechs could turn out to be worthless. But the cart got before the horse — by a few miles.
With CRISPR, We Could Change the Nature of Our Species. Should We?
This year we can expect to see large numbers of CRISPR gene-editing trials, but some are still afraid of this amazing technology.
Boys Only: Gene Editing That Can Change An Animal’s Sex
All on its own, the presence of SRY can make a female turn out to be essentially male—with bigger muscles, a penis, and testicles (although unable to make sperm).
Festival of Genomics London Themes…With a Twist!
With the Festival of Genomics London just around the corner, we thought it was the right time to turn our attention to the key themes being presented.
